OWD
CELG

Osborn Williams & Donohoe’s Celgene Corp CELG Stock Holding History

Osborn Williams & Donohoe’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-39,233
Closed -$3.9M – 320
2019
Q3 		$3.9M Sell
39,233
-1,808
-4% -$172K 0.39% 73
2019
Q2 		$3.79M Buy
41,041
+106
+0.3% +$10.1K 0.39% 74
2019
Q1 		$3.86M Buy
40,935
+9,665
+31% +$845K 0.4% 72
2018
Q4 		$2M Sell
31,270
-100
-0.3% -$7.38K 0.35% 72
2018
Q3 		$2.81M Buy
31,370
+300
+1% +$26.5K 0.44% 65
2018
Q2 		$2.47M Buy
31,070
+55
+0.2% +$4.57K 0.42% 67
2018
Q1 		$2.77M Buy
31,015
+2,440
+9% +$234K 0.48% 60
2017
Q4 		$2.98M Buy
28,575
+4,480
+19% +$506K 0.51% 57
2017
Q3 		$3.51M Sell
24,095
-65
-0.3% -$8.85K 0.63% 50
2017
Q2 		$3.14M Sell
24,160
-100
-0.4% -$12.3K 0.57% 54
2017
Q1 		$3.02M Hold
24,260
– – 0.55% 56
2016
Q4 		$2.81M Buy
24,260
+880
+4% +$98K 0.53% 58
2016
Q3 		$2.44M Hold
23,380
– – 0.47% 63
2016
Q2 		$2.31M Hold
23,380
– – 0.45% 66
2016
Q1 		$2.34M Hold
23,380
– – 0.47% 65
2015
Q4 		$2.8M Sell
23,380
-200
-0.8% -$23.1K 0.58% 55
2015
Q3 		$2.56M Hold
23,580
– – 0.55% 56
2015
Q2 		$3.18M Buy
23,580
+950
+4% +$109K 0.64% 51
2015
Q1 		$2.61M Hold
22,630
– – 0.51% 60
2014
Q4 		$2.53M Buy
22,630
+800
+4% +$84.4K 0.5% 60
2014
Q3 		$2.07M Buy
21,830
+200
+0.9% +$18K 0.43% 68
2014
Q2 		$1.93M Buy
21,630
+800
+4% +$60.8K 0.4% 72
2014
Q1 		$1.45M Sell
20,830
-200
-1% -$15.8K 0.32% 80
2013
Q4 		$1.78M Hold
21,030
– – 0.4% 73
2013
Q3 		$1.62M Hold
21,030
– – 0.4% 77
2013
Q2 		$1.23M Buy
+21,030
New +$1.27M 0.32% 82

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Osborn Williams & Donohoe's CELG Position: Q4 2019 in Review

Osborn Williams & Donohoe sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 39,233 shares — an estimated $3.9M sold.

Osborn Williams & Donohoe first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.9M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Osborn Williams & Donohoe reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 39,233 Celgene Corp shares in Q4 2019, an estimated $3.9M.
  • Osborn Williams & Donohoe first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Osborn Williams & Donohoe's Celgene Corp position peaked at $3.9M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q4 2019, filed 2 Mar 2020.